Khalid Yousef Aljamaan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Khalid Yousef Aljamaan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Zaheer Qureshi
Department of Physical Medicine and Rehabilitation, King Fahad Medical City, Riyadh, Saudi Arabia
1 shared publication - Amara Ilyas
Department of Physical Medicine and Rehabilitation, King Fahad Specialist Hospital, Damam 32553, Saudi Arabia
1 shared publication - Hasan Shacfe
Department of Physical Medicine and Rehabilitation, King Fahad Medical City, Riyadh 11525, Saudi Arabia
1 shared publication - Imad Saeed Moukais
Department of Physical Medicine and Rehabilitation, King Fahad Medical City, Riyadh 11525, Saudi Arabia
1 shared publication - Mohammed Jameel
King Fahad Medical City
1 shared publication - Saeed Bin Ayaz
Department of Physical Medicine and Rehabilitation, Combined Military Hospital, Jhelum, Pakistan
1 shared publication
Latest Publications
- Open Access
- 25 October 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (21) , 2820
Complications of Intrathecal Baclofen Pump Therapy: An Institutional Experience from Saudi Arabia
The intrathecal baclofen pump (ITB) is one of the advanced treatment options in the management of spasticity. This retrospective cohort study was conducted to identify the complications of ITB treatment at a tertiary care rehabilitation facility. Various demographic and technical factors were analyzed, which are less often reported in the literature. All patients with ITB who had their refill at the ITB clinic between November 2019 and March 2020 were included. Of 48 patients, 17 patients had 18 (37.5%) ITB-related complications. Catheter-related complications were most common, whereas loss of efficacy (16.7%) and baclofen withdrawal (14.5%) were the most common outcomes of complications. Only catheter occlusion had a significant relationship with the pattern of spastic quadriparesis (p = 0.001). Gender, rehabilitation diagnosis, patients’ residence, and facility of ITB placement did not have significant association. Similarly, age, distance from hospital, disease onset, ITB therapy duration, and baclofen dose were not statistically significant in relation to ITB-related complications.
- 25 October 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (21) , 2820
Open AccessComplications of Intrathecal Baclofen Pump Therapy: An Institutional Experience from Saudi Arabia
The intrathecal baclofen pump (ITB) is one of the advanced treatment options in the management of spasticity. This retrospective cohort study was conducted to identify the complications of ITB treatment at a tertiary care rehabilitation facility. Various demographic and technical factors were analyzed, which are less often reported in the literature. All patients with ITB who had their refill at the ITB clinic between November 2019 and March 2020 were included. Of 48 patients, 17 patients had 18 (37.5%) ITB-related complications. Catheter-related complications were most common, whereas loss of efficacy (16.7%) and baclofen withdrawal (14.5%) were the most common outcomes of complications. Only catheter occlusion had a significant relationship with the pattern of spastic quadriparesis (p = 0.001). Gender, rehabilitation diagnosis, patients’ residence, and facility of ITB placement did not have significant association. Similarly, age, distance from hospital, disease onset, ITB therapy duration, and baclofen dose were not statistically significant in relation to ITB-related complications.